Medical Care
Global Drug and Gene Delivery System Market Research Report 2025
- May 12, 25
- ID: 234375
- Pages: 96
- Figures: 100
- Views: 5
The global market for Drug and Gene Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug and Gene Delivery System in Diabetes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug and Gene Delivery System include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie, AstraZeneca, Bayer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug and Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug and Gene Delivery System.
The Drug and Gene Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug and Gene Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug and Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics
Segment by Type
Drug Delivery System
Gene Delivery System
Segment by Application
Diabetes
Central Nervous System
Infectious Disease
Oncology
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug and Gene Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Drug and Gene Delivery System in Diabetes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Drug and Gene Delivery System include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie, AstraZeneca, Bayer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug and Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug and Gene Delivery System.
The Drug and Gene Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug and Gene Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug and Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics
Segment by Type
Drug Delivery System
Gene Delivery System
Segment by Application
Diabetes
Central Nervous System
Infectious Disease
Oncology
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug and Gene Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug and Gene Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Delivery System
1.2.3 Gene Delivery System
1.3 Market by Application
1.3.1 Global Drug and Gene Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetes
1.3.3 Central Nervous System
1.3.4 Infectious Disease
1.3.5 Oncology
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug and Gene Delivery System Market Perspective (2020-2031)
2.2 Global Drug and Gene Delivery System Growth Trends by Region
2.2.1 Global Drug and Gene Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug and Gene Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Drug and Gene Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Drug and Gene Delivery System Market Dynamics
2.3.1 Drug and Gene Delivery System Industry Trends
2.3.2 Drug and Gene Delivery System Market Drivers
2.3.3 Drug and Gene Delivery System Market Challenges
2.3.4 Drug and Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug and Gene Delivery System Players by Revenue
3.1.1 Global Top Drug and Gene Delivery System Players by Revenue (2020-2025)
3.1.2 Global Drug and Gene Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Drug and Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug and Gene Delivery System Revenue
3.4 Global Drug and Gene Delivery System Market Concentration Ratio
3.4.1 Global Drug and Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug and Gene Delivery System Revenue in 2024
3.5 Global Key Players of Drug and Gene Delivery System Head office and Area Served
3.6 Global Key Players of Drug and Gene Delivery System, Product and Application
3.7 Global Key Players of Drug and Gene Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug and Gene Delivery System Breakdown Data by Type
4.1 Global Drug and Gene Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Drug and Gene Delivery System Forecasted Market Size by Type (2026-2031)
5 Drug and Gene Delivery System Breakdown Data by Application
5.1 Global Drug and Gene Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Drug and Gene Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug and Gene Delivery System Market Size (2020-2031)
6.2 North America Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug and Gene Delivery System Market Size by Country (2020-2025)
6.4 North America Drug and Gene Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug and Gene Delivery System Market Size (2020-2031)
7.2 Europe Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug and Gene Delivery System Market Size by Country (2020-2025)
7.4 Europe Drug and Gene Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug and Gene Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Drug and Gene Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug and Gene Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug and Gene Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug and Gene Delivery System Market Size (2020-2031)
9.2 Latin America Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug and Gene Delivery System Market Size by Country (2020-2025)
9.4 Latin America Drug and Gene Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug and Gene Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug and Gene Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug and Gene Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drug and Gene Delivery System Introduction
11.1.4 Pfizer Revenue in Drug and Gene Delivery System Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drug and Gene Delivery System Introduction
11.2.4 Johnson & Johnson Revenue in Drug and Gene Delivery System Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Drug and Gene Delivery System Introduction
11.3.4 Novartis Revenue in Drug and Gene Delivery System Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Drug and Gene Delivery System Introduction
11.4.4 Roche Revenue in Drug and Gene Delivery System Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Drug and Gene Delivery System Introduction
11.5.4 Merck & Co. Revenue in Drug and Gene Delivery System Business (2020-2025)
11.5.5 Merck & Co. Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Drug and Gene Delivery System Introduction
11.6.4 Sanofi Revenue in Drug and Gene Delivery System Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Drug and Gene Delivery System Introduction
11.7.4 GlaxoSmithKline Revenue in Drug and Gene Delivery System Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Drug and Gene Delivery System Introduction
11.8.4 AbbVie Revenue in Drug and Gene Delivery System Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Drug and Gene Delivery System Introduction
11.9.4 AstraZeneca Revenue in Drug and Gene Delivery System Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Drug and Gene Delivery System Introduction
11.10.4 Bayer Revenue in Drug and Gene Delivery System Business (2020-2025)
11.10.5 Bayer Recent Development
11.11 Bristol-MyersSquibb
11.11.1 Bristol-MyersSquibb Company Details
11.11.2 Bristol-MyersSquibb Business Overview
11.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Introduction
11.11.4 Bristol-MyersSquibb Revenue in Drug and Gene Delivery System Business (2020-2025)
11.11.5 Bristol-MyersSquibb Recent Development
11.12 Celgene
11.12.1 Celgene Company Details
11.12.2 Celgene Business Overview
11.12.3 Celgene Drug and Gene Delivery System Introduction
11.12.4 Celgene Revenue in Drug and Gene Delivery System Business (2020-2025)
11.12.5 Celgene Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Drug and Gene Delivery System Introduction
11.13.4 Amgen Revenue in Drug and Gene Delivery System Business (2020-2025)
11.13.5 Amgen Recent Development
11.14 Biogen
11.14.1 Biogen Company Details
11.14.2 Biogen Business Overview
11.14.3 Biogen Drug and Gene Delivery System Introduction
11.14.4 Biogen Revenue in Drug and Gene Delivery System Business (2020-2025)
11.14.5 Biogen Recent Development
11.15 Gilead Sciences
11.15.1 Gilead Sciences Company Details
11.15.2 Gilead Sciences Business Overview
11.15.3 Gilead Sciences Drug and Gene Delivery System Introduction
11.15.4 Gilead Sciences Revenue in Drug and Gene Delivery System Business (2020-2025)
11.15.5 Gilead Sciences Recent Development
11.16 Illumina
11.16.1 Illumina Company Details
11.16.2 Illumina Business Overview
11.16.3 Illumina Drug and Gene Delivery System Introduction
11.16.4 Illumina Revenue in Drug and Gene Delivery System Business (2020-2025)
11.16.5 Illumina Recent Development
11.17 Regeneron Pharmaceuticals
11.17.1 Regeneron Pharmaceuticals Company Details
11.17.2 Regeneron Pharmaceuticals Business Overview
11.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Introduction
11.17.4 Regeneron Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025)
11.17.5 Regeneron Pharmaceuticals Recent Development
11.18 Vertex Pharmaceuticals
11.18.1 Vertex Pharmaceuticals Company Details
11.18.2 Vertex Pharmaceuticals Business Overview
11.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Introduction
11.18.4 Vertex Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025)
11.18.5 Vertex Pharmaceuticals Recent Development
11.19 Moderna
11.19.1 Moderna Company Details
11.19.2 Moderna Business Overview
11.19.3 Moderna Drug and Gene Delivery System Introduction
11.19.4 Moderna Revenue in Drug and Gene Delivery System Business (2020-2025)
11.19.5 Moderna Recent Development
11.20 CRISPR Therapeutics
11.20.1 CRISPR Therapeutics Company Details
11.20.2 CRISPR Therapeutics Business Overview
11.20.3 CRISPR Therapeutics Drug and Gene Delivery System Introduction
11.20.4 CRISPR Therapeutics Revenue in Drug and Gene Delivery System Business (2020-2025)
11.20.5 CRISPR Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug and Gene Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Delivery System
1.2.3 Gene Delivery System
1.3 Market by Application
1.3.1 Global Drug and Gene Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diabetes
1.3.3 Central Nervous System
1.3.4 Infectious Disease
1.3.5 Oncology
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug and Gene Delivery System Market Perspective (2020-2031)
2.2 Global Drug and Gene Delivery System Growth Trends by Region
2.2.1 Global Drug and Gene Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug and Gene Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Drug and Gene Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Drug and Gene Delivery System Market Dynamics
2.3.1 Drug and Gene Delivery System Industry Trends
2.3.2 Drug and Gene Delivery System Market Drivers
2.3.3 Drug and Gene Delivery System Market Challenges
2.3.4 Drug and Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug and Gene Delivery System Players by Revenue
3.1.1 Global Top Drug and Gene Delivery System Players by Revenue (2020-2025)
3.1.2 Global Drug and Gene Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Drug and Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug and Gene Delivery System Revenue
3.4 Global Drug and Gene Delivery System Market Concentration Ratio
3.4.1 Global Drug and Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug and Gene Delivery System Revenue in 2024
3.5 Global Key Players of Drug and Gene Delivery System Head office and Area Served
3.6 Global Key Players of Drug and Gene Delivery System, Product and Application
3.7 Global Key Players of Drug and Gene Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug and Gene Delivery System Breakdown Data by Type
4.1 Global Drug and Gene Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Drug and Gene Delivery System Forecasted Market Size by Type (2026-2031)
5 Drug and Gene Delivery System Breakdown Data by Application
5.1 Global Drug and Gene Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Drug and Gene Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug and Gene Delivery System Market Size (2020-2031)
6.2 North America Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug and Gene Delivery System Market Size by Country (2020-2025)
6.4 North America Drug and Gene Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug and Gene Delivery System Market Size (2020-2031)
7.2 Europe Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug and Gene Delivery System Market Size by Country (2020-2025)
7.4 Europe Drug and Gene Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug and Gene Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Drug and Gene Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug and Gene Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug and Gene Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug and Gene Delivery System Market Size (2020-2031)
9.2 Latin America Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug and Gene Delivery System Market Size by Country (2020-2025)
9.4 Latin America Drug and Gene Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug and Gene Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Drug and Gene Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug and Gene Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug and Gene Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drug and Gene Delivery System Introduction
11.1.4 Pfizer Revenue in Drug and Gene Delivery System Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drug and Gene Delivery System Introduction
11.2.4 Johnson & Johnson Revenue in Drug and Gene Delivery System Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Drug and Gene Delivery System Introduction
11.3.4 Novartis Revenue in Drug and Gene Delivery System Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Drug and Gene Delivery System Introduction
11.4.4 Roche Revenue in Drug and Gene Delivery System Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Drug and Gene Delivery System Introduction
11.5.4 Merck & Co. Revenue in Drug and Gene Delivery System Business (2020-2025)
11.5.5 Merck & Co. Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Drug and Gene Delivery System Introduction
11.6.4 Sanofi Revenue in Drug and Gene Delivery System Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Drug and Gene Delivery System Introduction
11.7.4 GlaxoSmithKline Revenue in Drug and Gene Delivery System Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Drug and Gene Delivery System Introduction
11.8.4 AbbVie Revenue in Drug and Gene Delivery System Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Drug and Gene Delivery System Introduction
11.9.4 AstraZeneca Revenue in Drug and Gene Delivery System Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Drug and Gene Delivery System Introduction
11.10.4 Bayer Revenue in Drug and Gene Delivery System Business (2020-2025)
11.10.5 Bayer Recent Development
11.11 Bristol-MyersSquibb
11.11.1 Bristol-MyersSquibb Company Details
11.11.2 Bristol-MyersSquibb Business Overview
11.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Introduction
11.11.4 Bristol-MyersSquibb Revenue in Drug and Gene Delivery System Business (2020-2025)
11.11.5 Bristol-MyersSquibb Recent Development
11.12 Celgene
11.12.1 Celgene Company Details
11.12.2 Celgene Business Overview
11.12.3 Celgene Drug and Gene Delivery System Introduction
11.12.4 Celgene Revenue in Drug and Gene Delivery System Business (2020-2025)
11.12.5 Celgene Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Drug and Gene Delivery System Introduction
11.13.4 Amgen Revenue in Drug and Gene Delivery System Business (2020-2025)
11.13.5 Amgen Recent Development
11.14 Biogen
11.14.1 Biogen Company Details
11.14.2 Biogen Business Overview
11.14.3 Biogen Drug and Gene Delivery System Introduction
11.14.4 Biogen Revenue in Drug and Gene Delivery System Business (2020-2025)
11.14.5 Biogen Recent Development
11.15 Gilead Sciences
11.15.1 Gilead Sciences Company Details
11.15.2 Gilead Sciences Business Overview
11.15.3 Gilead Sciences Drug and Gene Delivery System Introduction
11.15.4 Gilead Sciences Revenue in Drug and Gene Delivery System Business (2020-2025)
11.15.5 Gilead Sciences Recent Development
11.16 Illumina
11.16.1 Illumina Company Details
11.16.2 Illumina Business Overview
11.16.3 Illumina Drug and Gene Delivery System Introduction
11.16.4 Illumina Revenue in Drug and Gene Delivery System Business (2020-2025)
11.16.5 Illumina Recent Development
11.17 Regeneron Pharmaceuticals
11.17.1 Regeneron Pharmaceuticals Company Details
11.17.2 Regeneron Pharmaceuticals Business Overview
11.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Introduction
11.17.4 Regeneron Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025)
11.17.5 Regeneron Pharmaceuticals Recent Development
11.18 Vertex Pharmaceuticals
11.18.1 Vertex Pharmaceuticals Company Details
11.18.2 Vertex Pharmaceuticals Business Overview
11.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Introduction
11.18.4 Vertex Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025)
11.18.5 Vertex Pharmaceuticals Recent Development
11.19 Moderna
11.19.1 Moderna Company Details
11.19.2 Moderna Business Overview
11.19.3 Moderna Drug and Gene Delivery System Introduction
11.19.4 Moderna Revenue in Drug and Gene Delivery System Business (2020-2025)
11.19.5 Moderna Recent Development
11.20 CRISPR Therapeutics
11.20.1 CRISPR Therapeutics Company Details
11.20.2 CRISPR Therapeutics Business Overview
11.20.3 CRISPR Therapeutics Drug and Gene Delivery System Introduction
11.20.4 CRISPR Therapeutics Revenue in Drug and Gene Delivery System Business (2020-2025)
11.20.5 CRISPR Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug and Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Delivery System
Table 3. Key Players of Gene Delivery System
Table 4. Global Drug and Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug and Gene Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug and Gene Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug and Gene Delivery System Market Share by Region (2020-2025)
Table 8. Global Drug and Gene Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug and Gene Delivery System Market Share by Region (2026-2031)
Table 10. Drug and Gene Delivery System Market Trends
Table 11. Drug and Gene Delivery System Market Drivers
Table 12. Drug and Gene Delivery System Market Challenges
Table 13. Drug and Gene Delivery System Market Restraints
Table 14. Global Drug and Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug and Gene Delivery System Market Share by Players (2020-2025)
Table 16. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2024)
Table 17. Ranking of Global Top Drug and Gene Delivery System Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug and Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug and Gene Delivery System, Headquarters and Area Served
Table 20. Global Key Players of Drug and Gene Delivery System, Product and Application
Table 21. Global Key Players of Drug and Gene Delivery System, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug and Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug and Gene Delivery System Revenue Market Share by Type (2020-2025)
Table 25. Global Drug and Gene Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug and Gene Delivery System Revenue Market Share by Type (2026-2031)
Table 27. Global Drug and Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug and Gene Delivery System Revenue Market Share by Application (2020-2025)
Table 29. Global Drug and Gene Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug and Gene Delivery System Revenue Market Share by Application (2026-2031)
Table 31. North America Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug and Gene Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug and Gene Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug and Gene Delivery System Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Drug and Gene Delivery System Product
Table 49. Pfizer Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Johnson & Johnson Company Details
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Drug and Gene Delivery System Product
Table 54. Johnson & Johnson Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Drug and Gene Delivery System Product
Table 59. Novartis Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Drug and Gene Delivery System Product
Table 64. Roche Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Merck & Co. Company Details
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Drug and Gene Delivery System Product
Table 69. Merck & Co. Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Drug and Gene Delivery System Product
Table 74. Sanofi Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Drug and Gene Delivery System Product
Table 79. GlaxoSmithKline Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Drug and Gene Delivery System Product
Table 84. AbbVie Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Drug and Gene Delivery System Product
Table 89. AstraZeneca Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Drug and Gene Delivery System Product
Table 94. Bayer Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Bristol-MyersSquibb Company Details
Table 97. Bristol-MyersSquibb Business Overview
Table 98. Bristol-MyersSquibb Drug and Gene Delivery System Product
Table 99. Bristol-MyersSquibb Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 100. Bristol-MyersSquibb Recent Development
Table 101. Celgene Company Details
Table 102. Celgene Business Overview
Table 103. Celgene Drug and Gene Delivery System Product
Table 104. Celgene Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 105. Celgene Recent Development
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Drug and Gene Delivery System Product
Table 109. Amgen Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 110. Amgen Recent Development
Table 111. Biogen Company Details
Table 112. Biogen Business Overview
Table 113. Biogen Drug and Gene Delivery System Product
Table 114. Biogen Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 115. Biogen Recent Development
Table 116. Gilead Sciences Company Details
Table 117. Gilead Sciences Business Overview
Table 118. Gilead Sciences Drug and Gene Delivery System Product
Table 119. Gilead Sciences Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 120. Gilead Sciences Recent Development
Table 121. Illumina Company Details
Table 122. Illumina Business Overview
Table 123. Illumina Drug and Gene Delivery System Product
Table 124. Illumina Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 125. Illumina Recent Development
Table 126. Regeneron Pharmaceuticals Company Details
Table 127. Regeneron Pharmaceuticals Business Overview
Table 128. Regeneron Pharmaceuticals Drug and Gene Delivery System Product
Table 129. Regeneron Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 130. Regeneron Pharmaceuticals Recent Development
Table 131. Vertex Pharmaceuticals Company Details
Table 132. Vertex Pharmaceuticals Business Overview
Table 133. Vertex Pharmaceuticals Drug and Gene Delivery System Product
Table 134. Vertex Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 135. Vertex Pharmaceuticals Recent Development
Table 136. Moderna Company Details
Table 137. Moderna Business Overview
Table 138. Moderna Drug and Gene Delivery System Product
Table 139. Moderna Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 140. Moderna Recent Development
Table 141. CRISPR Therapeutics Company Details
Table 142. CRISPR Therapeutics Business Overview
Table 143. CRISPR Therapeutics Drug and Gene Delivery System Product
Table 144. CRISPR Therapeutics Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 145. CRISPR Therapeutics Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. Drug and Gene Delivery System Picture
Figure 2. Global Drug and Gene Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug and Gene Delivery System Market Share by Type: 2024 VS 2031
Figure 4. Drug Delivery System Features
Figure 5. Gene Delivery System Features
Figure 6. Global Drug and Gene Delivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug and Gene Delivery System Market Share by Application: 2024 VS 2031
Figure 8. Diabetes Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Infectious Disease Case Studies
Figure 11. Oncology Case Studies
Figure 12. Other Case Studies
Figure 13. Drug and Gene Delivery System Report Years Considered
Figure 14. Global Drug and Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Drug and Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drug and Gene Delivery System Market Share by Region: 2024 VS 2031
Figure 17. Global Drug and Gene Delivery System Market Share by Players in 2024
Figure 18. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Drug and Gene Delivery System Revenue in 2024
Figure 20. North America Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 22. United States Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 26. Germany Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drug and Gene Delivery System Market Share by Region (2020-2031)
Figure 34. China Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 42. Mexico Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 46. Turkey Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 53. Merck & Co. Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 56. AbbVie Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 59. Bristol-MyersSquibb Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 60. Celgene Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 62. Biogen Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 63. Gilead Sciences Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 64. Illumina Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 65. Regeneron Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 66. Vertex Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 67. Moderna Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 68. CRISPR Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Drug and Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Delivery System
Table 3. Key Players of Gene Delivery System
Table 4. Global Drug and Gene Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Drug and Gene Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Drug and Gene Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Drug and Gene Delivery System Market Share by Region (2020-2025)
Table 8. Global Drug and Gene Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Drug and Gene Delivery System Market Share by Region (2026-2031)
Table 10. Drug and Gene Delivery System Market Trends
Table 11. Drug and Gene Delivery System Market Drivers
Table 12. Drug and Gene Delivery System Market Challenges
Table 13. Drug and Gene Delivery System Market Restraints
Table 14. Global Drug and Gene Delivery System Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Drug and Gene Delivery System Market Share by Players (2020-2025)
Table 16. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2024)
Table 17. Ranking of Global Top Drug and Gene Delivery System Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Drug and Gene Delivery System Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Drug and Gene Delivery System, Headquarters and Area Served
Table 20. Global Key Players of Drug and Gene Delivery System, Product and Application
Table 21. Global Key Players of Drug and Gene Delivery System, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug and Gene Delivery System Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Drug and Gene Delivery System Revenue Market Share by Type (2020-2025)
Table 25. Global Drug and Gene Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Drug and Gene Delivery System Revenue Market Share by Type (2026-2031)
Table 27. Global Drug and Gene Delivery System Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Drug and Gene Delivery System Revenue Market Share by Application (2020-2025)
Table 29. Global Drug and Gene Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Drug and Gene Delivery System Revenue Market Share by Application (2026-2031)
Table 31. North America Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Drug and Gene Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Drug and Gene Delivery System Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Drug and Gene Delivery System Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Drug and Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Drug and Gene Delivery System Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Drug and Gene Delivery System Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pfizer Company Details
Table 47. Pfizer Business Overview
Table 48. Pfizer Drug and Gene Delivery System Product
Table 49. Pfizer Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Johnson & Johnson Company Details
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Drug and Gene Delivery System Product
Table 54. Johnson & Johnson Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Drug and Gene Delivery System Product
Table 59. Novartis Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Drug and Gene Delivery System Product
Table 64. Roche Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Merck & Co. Company Details
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Drug and Gene Delivery System Product
Table 69. Merck & Co. Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Drug and Gene Delivery System Product
Table 74. Sanofi Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Drug and Gene Delivery System Product
Table 79. GlaxoSmithKline Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Drug and Gene Delivery System Product
Table 84. AbbVie Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Drug and Gene Delivery System Product
Table 89. AstraZeneca Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Drug and Gene Delivery System Product
Table 94. Bayer Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Bristol-MyersSquibb Company Details
Table 97. Bristol-MyersSquibb Business Overview
Table 98. Bristol-MyersSquibb Drug and Gene Delivery System Product
Table 99. Bristol-MyersSquibb Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 100. Bristol-MyersSquibb Recent Development
Table 101. Celgene Company Details
Table 102. Celgene Business Overview
Table 103. Celgene Drug and Gene Delivery System Product
Table 104. Celgene Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 105. Celgene Recent Development
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Drug and Gene Delivery System Product
Table 109. Amgen Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 110. Amgen Recent Development
Table 111. Biogen Company Details
Table 112. Biogen Business Overview
Table 113. Biogen Drug and Gene Delivery System Product
Table 114. Biogen Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 115. Biogen Recent Development
Table 116. Gilead Sciences Company Details
Table 117. Gilead Sciences Business Overview
Table 118. Gilead Sciences Drug and Gene Delivery System Product
Table 119. Gilead Sciences Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 120. Gilead Sciences Recent Development
Table 121. Illumina Company Details
Table 122. Illumina Business Overview
Table 123. Illumina Drug and Gene Delivery System Product
Table 124. Illumina Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 125. Illumina Recent Development
Table 126. Regeneron Pharmaceuticals Company Details
Table 127. Regeneron Pharmaceuticals Business Overview
Table 128. Regeneron Pharmaceuticals Drug and Gene Delivery System Product
Table 129. Regeneron Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 130. Regeneron Pharmaceuticals Recent Development
Table 131. Vertex Pharmaceuticals Company Details
Table 132. Vertex Pharmaceuticals Business Overview
Table 133. Vertex Pharmaceuticals Drug and Gene Delivery System Product
Table 134. Vertex Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 135. Vertex Pharmaceuticals Recent Development
Table 136. Moderna Company Details
Table 137. Moderna Business Overview
Table 138. Moderna Drug and Gene Delivery System Product
Table 139. Moderna Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 140. Moderna Recent Development
Table 141. CRISPR Therapeutics Company Details
Table 142. CRISPR Therapeutics Business Overview
Table 143. CRISPR Therapeutics Drug and Gene Delivery System Product
Table 144. CRISPR Therapeutics Revenue in Drug and Gene Delivery System Business (2020-2025) & (US$ Million)
Table 145. CRISPR Therapeutics Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. Drug and Gene Delivery System Picture
Figure 2. Global Drug and Gene Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug and Gene Delivery System Market Share by Type: 2024 VS 2031
Figure 4. Drug Delivery System Features
Figure 5. Gene Delivery System Features
Figure 6. Global Drug and Gene Delivery System Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug and Gene Delivery System Market Share by Application: 2024 VS 2031
Figure 8. Diabetes Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Infectious Disease Case Studies
Figure 11. Oncology Case Studies
Figure 12. Other Case Studies
Figure 13. Drug and Gene Delivery System Report Years Considered
Figure 14. Global Drug and Gene Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Drug and Gene Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Drug and Gene Delivery System Market Share by Region: 2024 VS 2031
Figure 17. Global Drug and Gene Delivery System Market Share by Players in 2024
Figure 18. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Drug and Gene Delivery System Revenue in 2024
Figure 20. North America Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 22. United States Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 26. Germany Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Drug and Gene Delivery System Market Share by Region (2020-2031)
Figure 34. China Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 42. Mexico Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Drug and Gene Delivery System Market Share by Country (2020-2031)
Figure 46. Turkey Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Drug and Gene Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 53. Merck & Co. Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 56. AbbVie Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 57. AstraZeneca Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 59. Bristol-MyersSquibb Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 60. Celgene Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 62. Biogen Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 63. Gilead Sciences Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 64. Illumina Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 65. Regeneron Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 66. Vertex Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 67. Moderna Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 68. CRISPR Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232